Aethlon Medical Files 8-K: Other Events Reported
Ticker: AEMD · Form: 8-K · Filed: Nov 6, 2025 · CIK: 882291
| Field | Detail |
|---|---|
| Company | Aethlon Medical Inc (AEMD) |
| Form Type | 8-K |
| Filed Date | Nov 6, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
AETH filed an 8-K for 'Other Events' on Nov 6, 2025. Details TBD.
AI Summary
Aethlon Medical, Inc. filed an 8-K on November 6, 2025, reporting on "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself.
Why It Matters
This filing indicates that Aethlon Medical has reported significant events to the SEC, but the lack of detail requires further investigation to understand the implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, making it difficult to assess the immediate risk without further information.
Key Players & Entities
- Aethlon Medical, Inc. (company) — Registrant
- November 6, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-37487 (identifier) — Commission File Number
- 13-3632859 (identifier) — IRS Employer Identification No.
- 11555 Sorrento Valley Road, Suite 203 (address) — Principal executive offices
- San Diego, California (location) — Principal executive offices city and state
- 92121 (zip_code) — Principal executive offices zip code
- ( 619 ) 941-0360 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Aethlon Medical, Inc. in this 8-K filing?
The filing states 'Other Events' as the item information but does not provide specific details within the provided text.
What is the exact date of the earliest event reported in this 8-K?
The date of the earliest event reported is November 6, 2025.
In which U.S. state is Aethlon Medical, Inc. incorporated?
Aethlon Medical, Inc. is incorporated in Nevada.
What is the principal executive office address for Aethlon Medical, Inc.?
The principal executive office address is 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121.
What is the Commission File Number for Aethlon Medical, Inc.?
The Commission File Number for Aethlon Medical, Inc. is 001-37487.
Filing Stats: 543 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2025-11-06 09:15:28
Key Financial Figures
- $0.001 — ange on which registered Common Stock, $0.001 par value per share AEMD The Nasdaq
- $1.00 — e "Common Stock"), had closed below the $1.00 per share minimum for 30 consecutive bu
Filing Documents
- aethlon_8k.htm (8-K) — 25KB
- 0001683168-25-008001.txt ( ) — 186KB
- aemd-20251106.xsd (EX-101.SCH) — 3KB
- aemd-20251106_lab.xml (EX-101.LAB) — 33KB
- aemd-20251106_pre.xml (EX-101.PRE) — 22KB
- aethlon_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events On November 5, 2025, Aethlon Medical, Inc., a Nevada corporation (the "Company") received a letter from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(2) (the "Minimum Bid Price Requirement") for continued listing on The Nasdaq Capital Market. As previously disclosed, on October 16, 2025, the Company received a letter from Nasdaq, notifying the Company that it was not in compliance with the Minimum Bid Price Requirement because the Company's common stock, par value $0.001 (the "Common Stock"), had closed below the $1.00 per share minimum for 30 consecutive business days. To regain compliance with the Minimum Bid Price Requirement, the Common Stock was required to maintain a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days. In its letter dated November 5, 2025, Nasdaq indicated the Company has regained compliance with the Minimum Bid Price Requirement, and the matter is now closed. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 6, 2025 Aethlon Medical, Inc. By: /s/ James B. Frakes Name: James B. Frakes Chief Executive Officer and Chief Financial Officer 3